Latest Posts
About This Stock
More About This Stock
Read
Read
Read
September Cannabis Category Performances Ranged From -6.3% To -39.0%
Article By:
Lorimer Wilson
Monday, October 3, 2022 9:27 AM EDT
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September and is -24.8% YTD.
In this article: BUD, MO, SMG, STZ, TAP, BTI, CGC, AAWH, ATAI, MNMD, CRLBF, CMPS, IMBBY, ZYNE, IIPR, GRWG, CRON, TPB, TLRY, ACB, GTBIF, TSNDF, PLNHF, CURLF, TCNNF, OGI, CCHWF (NOW CBSTF), JUSHF, ACRDF, ACRHF, SEEL, HYFM, VRNOF, AFCG, FORA, GDNSF, GHRS, ALID, CYBN, ATRWF
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
Article By:
Lorimer Wilson
Monday, September 19, 2022 9:30 AM EDT
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently.
In this article: BUD, MO, SMG, STZ, TAP, BTI, IMBBY, IIPR, GRWG, TPB, HYFM, AFCG, FORA, CGC, AAWH, ATAI, MNMD, CMPS, ZYNE, CRON, TLRY, ACB, OGI, SEEL, GHRS, ALID, CYBN, CRLBF, GTBIF, TSNDF, PLNHF, CURLF, TCNNF, AYRWF, CCHWF (NOW CBSTF), JUSHF, VRNOF, GDNSF
8 Largest Psychedelic Stocks Continued Their Decline Last Week
Article By:
Lorimer Wilson
Sunday, September 18, 2022 11:45 AM EDT
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks.